Rapidly discovering and extracting natural pharmaceuticals with Ben Lightburn, CEO of Filament Health

From Lab to Launch by Qualio

Mental health issues have been on the minds of many as athletes are under tremendous pressure to perform perfectly at the Olympics, and Filament Health is on a mission to get safe, natural psychedelics into the hands of everyone who needs them as soon as possible.

Today's guest is Ben Lightburn, CEO and Co-Founder of Filament Health, an exclusively natural psychedelic drug development company. Ben talks about rapidly discovering and extracting natural pharmaceuticals.

Ben is an entrepreneur specializing in the research, development, and commercialization of novel extraction technologies. He applies his background in botanical extraction to this emerging class of medicines.

Filament Health is building a platform to support the treatment of mental health conditions through GMP-compliant and FDA-approved psychedelic extracts from lab-grown and regeneratively harvested plants.

Key Takeaways:

• Insights on building a core team comfortable with operating in a startup environment
• Approach to patenting and clinical trial process, as well as regulations for psychedelics
• Common misconceptions about natural pharmaceuticals

Show Notes:

Filament Health

Filament Health - About Us

Filament Health - Our Technology

Good Manufacturing Practice (GMP)

U.S. Food and Drug Administration (FDA)

FDA - Breakthrough Therapy

U.S. Drug Enforcement Administration (DEA)

Health Canada

Mazza Innovation

Application to be on the show: From Lab to Launch

Qualio

Music by keldez

Qualio website:
https://www.qualio.com/

Previous episodes:
https://www.qualio.com/from-lab-to-launch-podcast

Apply to be on the show:
https://forms.gle/uUH2YtCFxJHrVGeL8

Music by keldez